Inovio Pharmaceuticals, Inc. (INO) Doubles Q2 Loss to 6c/Share; Issues Update

August 12, 2013 6:34 AM

Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q2 EPS of ($0.06), versus ($0.03) reported last year. Revenue for the quarter came ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found